Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026)

Voyager Therapeutics' (VYGR) quarterly Amortizatization of Intangibles came in at $365000.0 in Q1 2026, down 63.43% year-on-year from $998000.0 in Q1 2025, and down 84.97% quarter-over-quarter from $2.4 million in Q4 2025.

Voyager Therapeutics (VYGR) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Voyager Therapeutics has disclosed Amortizatization of Intangibles across 12 years of filings, most recently posting $365000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $365000.0, down 63.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 46.42% YoY), and the FY2025 annual result was $4.9 million, down 38.88% from the prior year.
  • Amortizatization of Intangibles came in at $365000.0 for Q1 2026 at Voyager Therapeutics, down from $2.4 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $4.5 million in Q4 2024 to a low of -$972000.0 in Q3 2024.
  • The 5-year median for Amortizatization of Intangibles is $365000.0 (2026), against an average of $893882.4.
  • Peak annual rise in Amortizatization of Intangibles reached 41625.0% in 2024, while the deepest fall reached 153.79% in 2024.
  • Voyager Therapeutics' Amortizatization of Intangibles stood at -$7000.0 in 2022, then surged by 2142.86% to $143000.0 in 2023, then jumped by 3079.02% to $4.5 million in 2024, then slumped by 46.59% to $2.4 million in 2025, then slumped by 84.97% to $365000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $365000.0 (Q1 2026), $2.4 million (Q4 2025), and $654000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Voyager Therapeutics 222.52 Mn 81.04 Mn - 365,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 365,000.00
Mar 31, 2026 365,000.00
Dec 31, 2025 2.43 Mn
Dec 31, 2025 2.43 Mn
Sep 30, 2025 654,000.00
Sep 30, 2025 654,000.00
Jun 30, 2025 791,000.00
Jun 30, 2025 791,000.00
Mar 31, 2025 998,000.00
Mar 31, 2025 998,000.00
Dec 31, 2024 4.55 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 -972,000.00
Sep 30, 2024 -972,000.00
Jun 30, 2024 3.34 Mn
Jun 30, 2024 3.34 Mn
Mar 31, 2024 1.06 Mn
Mar 31, 2024 1.06 Mn
Dec 31, 2023 143,000.00
Dec 31, 2023 143,000.00